IL36A/IL1F6 Antikörper (AA 1-158)

Produktnummer ABIN2609921

Produktdetails anti-IL36A/IL1F6 Antikörper

Target: IL36A/IL1F6 (IL1F6) (Interleukin 1 Family, Member 6 (IL1F6))

Bindungsspezifität: AA 1-158

Reaktivität: Human

Wirt: Maus

Klonalität: Polyklonal

Konjugat: Dieser IL36A/IL1F6 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Spezifität: Human IL36A

Aufreinigung: Affinity purified

Immunogen: Full length human IL1F6, aa1-158 (NP_055255.1).

Type of Immunogen: Recombinant protein

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Kommentare:

Target Species of Antibody: Human

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: PBS,  pH 7.2.

Handhabung: Aliquot to avoid repeated freezing and thawing.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for at least 1 year.

Details zu IL36A/IL1F6

Target: IL36A/IL1F6 (IL1F6) (Interleukin 1 Family, Member 6 (IL1F6))

Andere Bezeichnung: IL36A (IL1F6 Produkte)

Synonyme: Il1f6 antikoerper, Fil1 antikoerper, IL-1H1 antikoerper, IL1RP2 antikoerper, Il1f9 antikoerper, Il36a antikoerper, FIL1 antikoerper, FIL1(EPSILON) antikoerper, FIL1E antikoerper, IL-1F6 antikoerper, IL1(EPSILON) antikoerper, IL1F6 antikoerper, interleukin 36, alpha antikoerper, interleukin 1 family, member 6 (epsilon) antikoerper, interleukin 1 family, member 6 antikoerper, interleukin 36 alpha antikoerper, Il36a antikoerper, IL1F6 antikoerper, IL36A antikoerper, Il1f6 antikoerper

Hintergrund: Name/Gene ID: IL36A
Family: IL-1

Synonyms: IL36A, FIL1, FIL1 epsilon, IL-1F6, IL1(EPSILON), IL1E, IL1F6, Interleukin 1, epsilon, Interleukin 36, alpha, Interleukin-1 epsilon, Interleukin-1 family member 6, FIL1(EPSILON), FIL1E, IL-1 epsilon, IL-1F6 (FIL-1-epsilon), Interleukin-36 alpha

Gen-ID: 27179

NCBI Accession: NP_055255

Pathways: Cancer Immune Checkpoints